Long acting injectable(LAI) Feasibility Study in Rwandan Health Care Settings

Principal investigator: Yvonne KAYITESHONGA
Check PI profile

Investigators

Virginia Smith-Swintosky, Alexander Keenan, Kivwanga Mwaniki, Tony Thomas, Jean Damascene Iyamuremye, Alfred Ngirababyeyi, Jean Baptiste Byiringiro, Pacifique Gisele Mukashema, Christian Ishimwe, Pascal Kayobotsi, Yvonne Kayiteshonga

Study information

  • Research Area: Mental Health
  • Research type: Economic research
  • Start date: Oct 01, 2018
  • End date: Dec 30, 2022

Study aim of the objectives

This study will construct a health economic model to illustrate the health, economic and social impacts of different
treatments for schizophrenia in Rwanda and determine the health economic value of long-acting injectables (LAIs) for the treatment of schizophrenia in Rwanda.

Study setting/Area (Location)

Ruhengeri & NEURO-PSYCHIATRIC HOSPITAL CARAES NDERA

Implementing institution

J&J and Rwanda Biomedical Center

Department/Division

Mental Health Division

Impact on Policy

The findings of this study will inform the treatment guideline of schizophrenia in Rwanda

Study implementation progress

Related research

Login
Support